News

Merck, known as MSD outside the United States and Canada, confirmed it has signed a definitive agreement to acquire Terns Pharmaceuticals in a deal valued at approximately $6.7 billion. The transaction, priced at $53.00 per share in cash, has...

Healthcare organizations across the country are expanding their provider networks to meet growing demand. Population growth, physician shortages in certain specialties, and the rise of large integrated health systems are pushing hospitals to recruit more clinicians and extend their...

Axplora has reached a key milestone in its ongoing investment strategy, advancing a $60 million programme dedicated to strengthening HPAPI manufacturing capabilities at its Farmabios site in Gropello Cairoli. The latest development involves the construction of a new 4,500...

ICON, a world-leading clinical research organisation, has formalised a definitive partnership agreement with Advarra to introduce a new research-ready trial model designed to reshape how clinical trials are conducted. The collaboration brings together ICON’s global clinical trial solutions with...

Novartis is stepping up its presence in China with a fresh wave of capital deployment, underscoring the country’s growing role in global pharmaceutical strategy. The company confirmed a Novartis China investment exceeding 3.3 billion Chinese yuan (roughly $480 million),...

The NHS has partnered with leading pharmaceutical companies to establish a £10 million Respiratory Transformation Partnership, a coordinated programme designed to improve care delivery for asthma and chronic obstructive pulmonary disease (COPD) patients across England while easing systemic pressure...

Pharmaceutical companies spend extraordinary amounts optimising what they can see. R&D pipelines. Manufacturing yields. Sales force efficiency. Regulatory submission timelines. These are the numbers that get reviewed in board meetings and benchmarked against competitors. Meanwhile, a completely different category of...